Markets

Becton, Dickinson: Enteric Parasite Panel Gets FDA Approval

BD Life Sciences - a division of Becton, Dickinson and Company or BD BDX -- recently announced FDA approval for BD MAX Enteric Parasite Panel, to be used in the BD MAX System.

The BD MAX system is a fully-integrated, automated molecular platform which can run both In Vitro Diagnostics (IVD) and open system assays in a flexible and efficient manner. BD MAX Enteric Parasite Panel, which helps to diagnose infectious gastroenteritis, is the latest entry in the BD MAX Enteric range of assays.

The BD MAX Enteric Parasite Panel is an IVD test, which is used to detect DNA from Giardia lamblia, Cryptosporidium (C. hominis and C. parvum) and Entamoeba histolytica in both unpreserved and 10% formalin-fixed stool specimens.

The existing BD MAX Enteric Bacterial Panel spots pathogens, responsible for nearly 95% of the bacteria causing gastroenteritis. With the new Parasite Panel, the majority of pathogens can be detected. Notably, the panel gained CE Mark approval in May 2014 and since then it is available in the European market

.

Reportedly, diarrhea is the cause of over 2 million deaths each year. Conventional methods take 2-3 days to detect the viruses, bacteria or parasites causing the infection. In such a scenario, we believe the new assay from BD holds immense market potential.

Meanwhile, management is focused on expanding the BD MAX assay portfolio. Recently, BD and Seegene came together to develop multiplex real-time PCR reagents for the BD MAX System. Seegene's multiplex reagents possess the ability to concurrently spot and recognize various categories of pathogens in a single test.

Zacks Rank and Key Picks

Currently, BD carries a Zacks Rank #3 (Hold). Better-ranked stocks in the medical sector are Masimo MASI , Thoratec THOR and NuVasive NUVA with a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

THORATEC CORP (THOR): Free Stock Analysis Report

BECTON DICKINSO (BDX): Free Stock Analysis Report

MASIMO CORP (MASI): Free Stock Analysis Report

NUVASIVE INC (NUVA): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NUVA BDX MASI

Other Topics

Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More